The technical and economic advantage of using zebrafish is due to the ability to study multiple organisms in a reduced space.
In Conversation
... Andalusia’s hospitals have never been fully saturated throughout the entire pandemic, which has allowed us to be supportive of other regions, sending ventilators and receiving…
Accord recognises biosimilars as a future growth driver for the company. It is common sense as medicine moves to biologics and biologics move toward gene and…
We truly believe that our R&D expertise, partnership appeal and focused go-to-market model make a recipe for success
The first of ADL Biopharma’s advantages is our pharma background, which guarantees the highest level of quality and reliability ...
Due to the nature of our products, the pandemic represented a huge surge in demand for us
Spain has an extraordinary talent base from which to choose, as well as state-of-the-art universities
One in ten generics prescriptions in Spain – more than half of what retail pharmacies dispense to patients – are Teva products
The pandemic has put [the medtech] sector in the spotlight, and we have shown that we are an innovative and committed industry
While the performance of the Spanish R&I system still lags behind the EU average in many indicators, its biotech ecosystem has been able to mature, growing…
The market share of biosimilars in Spain has been increasing but the returns on investment have decreased steadily
In retrospect, putting all our resources and efforts into becoming one of the best vaccine developers in the world has made HIPRA a great organisation
